First, the infection must get inside the cell. Every infection does this slightly differently, but most use their signature “spikes” to fuse themselves to a cell’s outer membrane and then squeeze their way inside.

Once inside, the infection RNA instructs the cell to make a long polypeptide containing special enzymes. This long protein must be cut apart for the virus to replicate. To accomplish this, the infection encodes a special ‘scissors’, called 3CL protease, which cuts up the polypeptide into the different enzymes that then become functional.

Before these enzymes can start working, they need to be separated from each other. The protease enzyme acts like a pair of scissors, cutting the polypeptide up into the different enzymes that then become functional.

Protease inhibitors*, like Tollovid, are designed to tightly bind to the protease enzyme, blocking its ability to cut. This shuts down the entire infection-cloning apparatus, leaving it unable to replicate.

CGMP refers to the Current Good Manufacturing Practice regulations enforced by the FDA. CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. When you purchase Tollovid, you can be assured that it adheres to the CGMP regulations that assure the identity, strength, quality, and purity.

Informed Sport is a global testing and certification program for sports and nutritional supplements. Tollovid is tested by LGC Group’s world-class anti-doping laboratory for contamination against a broad range of banned substances in sport, using ISO 17025 accredited methods. When you see the Informed Sport quality mark for Tollovid, you can be assured that it has passed the most stringent sports supplements testing.

Half-maximal inhibitory concentration (IC50) is the most widely used and informative measure of efficacy. It indicates how much is needed to inhibit a biological process by half, thus providing a measure of potency. With Tollovid, you can rest assured that it has been tested for the best and only measurement of 3CL protease inhibition.

With our IRB-waived market research self-reported questionnaire, we have studied emerging evidence concerning positive clinical and immunological impacts of supplementation with Tollovid.